Affordable Microbial Feedstock
Microbial oil production decouples FAME price from volatile commodity vegetable oil markets, providing a low-cost, sustainable alternative .
Biodiesel, typically in the form of Fatty Acid Methyl Esters (FAME), is a leading candidate for renewable liquid transportation fuel. Its commercialization is significantly challenged by the high cost of raw materials (traditional vegetable oils or animal fats) and the low efficiency of the ester exchange (transesterification) reaction when using enzymatic catalysts.
CD Biosynsis offers a synthetic biology service focused on both microbial feedstock generation and process efficiency. Our core strategy involves the modification of oil-producing yeast lipid synthesis pathway to maximize the yield of affordable, microbial oil (single-cell oil) as a direct replacement for costly traditional feedstocks. This is combined with the directed evolution of lipase enzymes to optimize their activity, solvent tolerance, and thermal stability, significantly improving the efficiency of the transesterification step. This integrated approach aims to deliver an economically competitive and environmentally sustainable bioproduction platform for FAME.
Get a QuoteThe economic viability of biobased FAME is constrained by these major hurdles:
A cost-effective solution requires both a cheaper, high-yield feedstock and a more efficient biocatalytic conversion process.
CD Biosynsis addresses feedstock and conversion challenges through metabolic and enzyme engineering:
Modification of Oil-Producing Yeast Lipid Synthesis Pathway
We employ CRISPR and genome editing to upregulate key lipid accumulation enzymes (DGA1) and downregulate competing pathways, maximizing TAG (Triacylglycerol) yield from low-cost carbon sources.
Directed Evolution of Lipase for Optimization
We use directed evolution to enhance the lipase biocatalyst, focusing on increased solvent (methanol) tolerance , thermal stability, and higher specific activity for FAME production.
Glycerol Metabolism Engineering
We modify the yeast's central metabolism to enable the conversion of the glycerol byproduct into valuable products or back into the FAME synthesis pathway, improving process economics.
Simultaneous Oil Synthesis and Transesterification
We explore whole-cell catalysis by engineering the oleaginous yeast to express the optimized lipase on its surface or within lipid bodies, enabling single-step conversion.
This systematic approach is focused on lowering feedstock costs through microbial oil and improving the efficiency of the enzymatic conversion process.
Our Biodiesel engineering service is dedicated to pursuing the following production goals:
Affordable Microbial Feedstock
Microbial oil production decouples FAME price from volatile commodity vegetable oil markets, providing a low-cost, sustainable alternative .
Enhanced Transesterification Rate
Optimized lipase and whole-cell catalysts are focused on achieving a faster, more complete conversion of TAG to FAME.
Improved Biocatalyst Robustness
Engineered lipases exhibit higher tolerance to methanol and higher temperatures , making the enzymatic process more industrial-friendly.
Sustainable Production Route
Biocatalysis is a non-toxic, non-corrosive process that reduces chemical waste compared to conventional chemical conversion.
Cost Reduction Potential
Reduced feedstock cost and improved conversion efficiency are focused on achieving economic parity with fossil fuels . [Image of Cost Reduction Icon]
We provide an integrated platform aimed at maximizing the yield and minimizing the cost of FAME production.
Our Biodiesel engineering service follows a standardized, integrated research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding lipid yield and conversion efficiency.
Explore the potential for a cost-competitive, sustainable Biodiesel supply. CD Biosynsis provides customized strain and enzyme engineering solutions:
What is the difference between oil-producing yeast and other feedstocks?
Oil-producing yeast (oleaginous yeast) can synthesize and accumulate lipids (oils) rapidly using low-cost carbon sources (like industrial waste streams), making them a sustainable and less commodity-dependent source of oil compared to soybeans or palm oil.
Why use lipase for transesterification instead of chemical catalysts?
Enzymatic conversion using lipase is performed under milder conditions (pH-neutral, lower temperature), avoids soap formation, and can handle low-quality feedstocks (high free fatty acids) without pretreatment, leading to simpler downstream purification .
What is a TAG (Triacylglycerol)?
TAG is the primary form of fat storage in organisms and the main component of vegetable oils and microbial lipids. It consists of a glycerol backbone esterified to three fatty acid chains . The goal of transesterification is to remove the glycerol and replace it with methanol to form FAME.
What is the impact of methanol tolerance on lipase?
Methanol is a required reactant, but it is also a potent denaturant for many enzymes. Enhancing lipase's tolerance to high methanol concentrations is critical for achieving industrial-relevant reaction rates without enzyme deactivation.
What is the estimated project timeline?
A project involving both pathway engineering and enzyme directed evolution typically requires 24-28 weeks for final strain and biocatalyst delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.